The Boeing Company stock draws bullish analyst targets up to $295 amid 787 delivery resumption and production challenges

The Boeing Company stock (ISIN: US0970231058) gains traction on NYSE at 198.48 USD as of March 24, 2026, with Jefferies holding 'Buy' at $295 and regulatory nod restarting 787 Dreamliner deliveries, signaling backlog recovery for US investors amid execution risks.

The Boeing Company stock has captured renewed Wall Street attention as analysts uphold bullish stances amid key regulatory progress on the 787 Dreamliner program. Shares on the NYSE stood at 198.48 USD as of March 24, 2026, marking a 1.72% rise despite ongoing production hurdles. This development underscores Boeing's potential to tackle a massive commercial backlog while defense contracts offer stability for US investors.

As of: 25.03.2026

Elena Vargas, Aerospace Sector Analyst: Boeing's regulatory wins on the 787 highlight a pivotal shift toward execution in commercial aviation, balancing defense resilience for discerning US portfolios.

Analyst Upgrades Sustain Momentum Despite Headwinds

Jefferies maintained its 'Buy' recommendation on The Boeing Company stock on March 24, 2026, setting a price target of 295 USD on the NYSE. This reflects strong underlying demand for the 737 MAX and 787 Dreamliner, core to Boeing's commercial recovery. RBC Capital Markets echoed optimism with an 'Outperform' rating and 275 USD target from March 17, 2026, noting limited exposure to Middle East tensions at just 6% of combined Airbus-Boeing deliveries.

Wolfe Research and Tigress Financial also reaffirmed 'Buy' ratings in the prior week, pointing to consensus upside exceeding 36% from levels near 198 USD on NYSE. These updates arrive as Boeing addresses production pauses, reinforcing analyst faith in the firm's order backlog surpassing 5,000 aircraft.

For US investors, this analyst chorus signals leverage from rising deliveries against years of cash burn in commercial operations. Defense segment steadiness adds a buffer, with recent wins bolstering revenue diversity.

787 Dreamliner Deliveries Resume After Regulatory Green Light

A critical regulatory approval has enabled Boeing to restart 787 Dreamliner deliveries following a brief halt in early March 2026 due to cabling concerns. This milestone clears a path to fulfill orders in a backlog valued at hundreds of billions, vital for cash flow revival. The move addresses execution risks that have plagued Boeing's commercial division, where production ramps remain key to profitability.

Recent commitments, such as Aviation Capital Group's order for 50 737 MAX jets and Alaska Airlines' historic largest-ever purchase, underscore demand resilience. Analysts project commercial revenues approaching 50 billion USD annually by 2028, predicated on monthly production hitting 38-42 jets. US investors stand to gain from this trajectory, as improved free cash flow could fund dividends or buybacks long absent.

Defense Segment Provides Downside Protection

Boeing's defense business emerges as a stabilizing force for The Boeing Company stock, with contracts shielding against commercial volatility. Inclusion in the Euronext Aerospace and Defense index alongside peers like GE Aerospace highlights sector positioning. US investors value this, as Pentagon budgets sustain demand for platforms amid geopolitical shifts.

Recent defense wins complement commercial orders, diversifying revenue streams. While commercial aviation drives growth, defense ensures baseline cash generation, crucial after prolonged losses. This balance appeals to portfolios seeking aerospace exposure with reduced cyclical risk.

US Investor Relevance in a Recovery Play

For US investors, The Boeing Company stock represents a high-conviction recovery bet on American manufacturing leadership. NYSE listing at 198.48 USD as of March 24, 2026, positions it for domestic retirement accounts and growth allocations. Analyst targets to 295 USD imply substantial rerating if production milestones materialize.

FAA oversight, a US regulatory hallmark, enforces quality while spurring efficiency. Combined with 737 MAX demand from US carriers like Alaska Airlines, this fosters direct economic ties. Investors monitoring Q4 results on January 27 gain early signals on guidance, making Boeing a watchlist staple.

Execution Risks and Open Questions Remain

Persistent production challenges pose risks to The Boeing Company stock's upside. Past halts, like the recent 787 cabling issue, highlight supply chain and quality control vulnerabilities. Investors must weigh if regulatory approvals translate to sustained ramps amid labor and supplier constraints.

Geopolitical factors, though minor at 6% exposure, add uncertainty. Broader market pressures could cap gains near 200 USD on NYSE if cash flow disappoints. Strategic patience is essential, with downside protected by defense but leverage tied to commercial execution.

Disclaimer: This is not investment advice. Stocks are volatile financial instruments.